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ABSTRACT  
Selenocysteine (Sec) is a naturally occurring amino acid that is also referred to as the 21st amino acid. 
Site-specific incorporation of Sec into proteins is attractive, because the reactivity of a selenol group 
exceeds that of a thiol group and thus allows site-specific protein modifications. It is incorporated into 
proteins by an unusual enzymatic mechanism which, in E. coli and other organisms, involves the 
recognition of a selenocysteine insertion sequence (SECIS) in the mRNA of the target protein. 
Reengineering of the natural machinery for Sec incorporation at arbitrary sites independent of SECIS 
elements, however, is challenging. Here we demonstrate an alternative route, whereby a photocaged 
selenocysteine (PSc) is incorporated as an unnatural amino acid in response to an amber stop codon, using 
a mutant Methanosarcina mazei pyrrolysyl-tRNA synthetase, Mm PCC2RS, and its cognate tRNACUA. 
Following decaging by UV irradiation, proteins synthesized with PSc are readily tagged, e.g. with NMR 
probes to study ligand binding by NMR spectroscopy. The approach provides a facile route for genetically 
encoded Sec incorporation. It allows the production of pure selenoproteins and the Sec residue enables 
site-specific covalent protein modification with reagents that would usually react first with naturally 
occurring cysteine residues. The much greater reactivity of Sec residues allows their selective alkylation 






Site-specific protein modification is a fundamental tool for a myriad of applications in protein 
chemistry, including protein immobilization on surfaces, enhancement of protein solubility by 
PEGylation, production of therapeutic conjugates with drugs, mimicking of natural post-translational 
modifications, and introduction of tags for structural studies by fluorescence resonance energy transfer 
(FRET), electron paramagnetic resonance (EPR) spectroscopy, or nuclear magnetic resonance (NMR) 
spectroscopy.1−8 Cysteine is the most convenient target for protein modification as it is the most 
nucleophilic and oxidation-sensitive among the 20 canonical amino acids. Thus site-directed 
modifications of proteins are often carried out on cysteine residues with the formation of disulfide or 
thioether bonds. To be site-selective, however, this approach requires that only a single cysteine residue 
is amenable to the chemical reaction, which is difficult when the protein of interest contains other cysteine 
residues that are essential for the structure or function of the protein. In principle, this problem can be 
solved by genetic encoding of photocaged cysteine (PCC) as an unnatural amino acid (UAA),9 which 
enables a protocol involving the chemical protection of the native cysteine residues, decaging of the PCC 
residue and chemical modification and deprotection of the native cysteine residues.10 Charging of the 
cognate amber suppressor tRNACUA with the PCC amino acid is elegantly achieved by a mutant 
Methanosarcina barkeri pyrrolysyl-tRNA synthetase (Mb PylRS), named PCC2RS,9 but the number of 
steps involved in selective cysteine labeling renders the overall process unattractive. A more 
straightforward alternative is to incorporate a Sec residue, which is chemically more reactive than 
cysteine, obviating the need for protection of any native cysteine residues. Sec is chemically similar to 
cysteine but has a significantly lower pKa value (5.2 versus 8.5).11−13 This can be exploited for selective 
modifications of Sec residues in the presence of native cysteine residues at slightly acidic pH values.14−17 
A recent, very attractive application harnesses the exceptional reactivity of Sec residues for expressed 
protein-ligation.17−19 
Site-specific incorporation of Sec is challenging. The natural mechanism employs a highly 
specialized translation system, relying on a specific tRNA (tRNASec), selenophosphate synthase (SelD), 
Sec synthase (SelA), a special EF-Tu-independent elongation factor (SelB), and a conserved mRNA 
sequence (selenocysteine insertion sequence or SECIS) in the vicinity of the target UGA codon. The 
requisite mRNA stem-loop structure comprised by the SECIS element restricts the sequence context 
where Sec residues can be positioned.11,13 In an E. coli strain devoid of the release factor 1 (RF1), the 
SECIS/SelB system has also successfully been harnessed for the synthesis of pure selenoproteins using a 
UAG (amber) codon instead of the usual UGA codon but, in the absence of the SECIS element, this 
approach results in full-length protein due to misincorporation of natural amino acids.20 Site-selective Sec 
incorporation at an amber stop codon independent of SelB and the SECIS element has also been 
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demonstrated, using a tRNASec engineered for EF-Tu–mediated Sec incorporation.21−24 At present, this 
approach is limited to low yields of selenoproteins (<0.5 mg/L cell culture), and further optimization of 
the engineered tRNASec is difficult to conceive as it needs to be recognized both by SelA and EF-Tu.25 
Poor expression yields thus have prevented the use of this approach for subsequent applications that 
require larger protein quantities, such as NMR spectroscopy or expressed protein ligation. The problem 
of low yield is circumvented by a new system for EF-Tu mediated selenocysteine incorporation at amber 
codons, which uses Aeromonas salmonicida selenocysteine synthase (SelA) to convert Ser-allo-tRNA 
into Sec-allo-tRNA which is efficiently recognized by EF-Tu.26 The system can be used to obtain 
selenoproteins in high yields, but it is prone to incorporation of serine in place of selenocysteine due to 
incomplete conversion of Ser to Sec by SelA. This makes the strategy critically dependent on optimization 
of the relative expression levels of allo-tRNA and SelA as well as the expression temperatures, which are 
different for different proteins.26  
The wide interest in Sec incorporation has triggered the development of a range of alternative 
strategies for the production of selenoproteins, in particular focusing on expression in E. coli, which is 
the most readily used organism for protein production. In a straightforward way, cysteine residues can 
globally be replaced by Sec by misloading the cysteinyl-tRNA with Sec in a growth medium 
supplemented with Sec, but incorporation of cysteine cannot be completely avoided in this approach and 
site-selectivity is achieved only if the native protein sequence contains only a single cysteine residue,27 or 
a Sec-containing fragment is post-translationally ligated with a separately produced polypeptide.17 As an 
alternative, it has been shown that a photocaged Sec, 4,5-dimethoxy-2-nitrobenzyl-Sec (DMNB-Sec), can 
be incorporated as a UAA in yeast by genetic encoding based on an orthogonal LeuRS/tRNACUA pair, 
with subsequent decaging providing a straightforward route to a site-specific Sec residue.16 This system, 
however, requires high concentrations of DMNB-Sec (3 mM) to suppress erroneous incorporation of 
leucine and isoleucine,16 and cannot be used in E. coli, which limits its applications, e.g., making it 
difficult to produce isotope-labeled proteins. The misincorporation of leucine and isoleucine appears to 
be intrinsic, as it has also been observed in the corresponding system established for DMNB-Ser.28 A 
cost-effective general method is yet to be established that works in E. coli and produces selenoproteins in 
sufficient yield and with reproducible purity (>90%) to render Sec incorporation attractive for site-specific 
chemical modifications for studies by NMR spectroscopy.  
The present study is based on the hypothesis that the pyrrolysine system developed for the 
incorporation of photocaged cysteine, PCC, at amber stop codons could be adapted for the incorporation 
of the seleno-analogue of PCC (Figure 1A). Incorporation of selenocysteine as a photocaged unnatural 
amino acid (PSc) not only provides the required specificity, but also minimizes losses arising from the 
high reactivity of free selenol groups, as decaging of the PSc residue can be performed on the purified 
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protein and the product can be subjected to further reactions immediately and under controlled conditions. 
In our hands, the wild-type pyrrolysyl-tRNA synthetase from Methanosarcina mazei (Mm) had performed 
well in different experiments for the incorporation of Boc-lysine at amber stop codons. Therefore, we 
transferred the mutations reported for the Mb PCC2RS enzyme to the corresponding synthetase from 
Methanosarcina mazei to produce Mm PCC2RS, and tested the incorporation of PSc in two different 
proteins. The strategy involves the expression of the target protein in a two-plasmid system in E. coli, 
with the suppressor tRNA and aminoacyl-tRNA synthetase on one vector and the target protein on the 
other, followed by protein purification, decaging and reaction of the selenocysteine with an alkylating 
agent (Figure 1B). We demonstrate that this strategy yields selenocysteine proteins with very high purity 
and in sufficient yield for NMR studies. Finally, we demonstrate that this approach allows quantitative 
and selective covalent protein modification with reagents, which would usually react with solvent-
exposed cysteine residues. Due to the much greater reactivity of selenocysteine, competing reactions of 
solvent-exposed cysteine residues were undetectable. 
 
Figure 1. Genetically encoded incorporation of PSc into proteins in E. coli. (A) Chemical structure of 
photocaged selenocysteine (PSc). The red moiety is the caging group that is released upon UV irradiation. 




RESULTS AND DISCUSSION 
PSC incorporation into proteins 
The gene of the Mm PCC2RS enzyme was cloned into a pCDF vector that also contained the gene of the 
cognate tRNACUA.29 The amino acid residues lining the substrate binding pockets of MmPylRS and 
MbPylRS are highly conserved between both enzymes, so that the specificity-changing mutations in Mb 
PCC2RS were easily transferred to make Mm PCC2RS. Denoting the unnatural amino acid PSc or Sec as 
“U”, the mutant H147U of E. coli peptidyl-prolyl cis-trans isomerase B (PpiB H147U) and the mutant 
V36U of the Zika virus NS2B-NS3 protease (ZiPro V36U) were selected as model proteins to demonstrate 
the incorporation of PSc by the Mm PCC2RS/tRNACUA pair. Both wild-type proteins contain cysteine 
residues and the cysteine residues in ZiPro are fully solvent exposed (Figure S1). Production of full-length 
PpiB H147U and ZiPro V36U in E. coli BL21(DE3) depended on the addition of PSc (Figure 2B). As the 
amber stop codon is recognized both by tRNACUA and RF1, truncated proteins are an unavoidable side 
product. To obtain pure full-length proteins, we expressed them with a C-terminal His6-tag and purified 
using a Ni-NTA column (Figure 2B).  
 
Figure 2. SDS-PAGE analysis of the expression and purification of PpiB H147U and ZiPro V36U, where 
U stands for PSc. (A) Expression of PpiB H147U (left panel) and ZiPro V36U (right panel). M: marker 
lane; BI and AI: before and after induction with IPTG, showing the total cellular protein of E. coli. The 
bands of full-length protein, truncated protein and Mm PCC2RS are marked. Truncated ZiPro (9.5 kDa) 
is not visible in the gel. (B) PpiB H147U and ZiPro V36U expressed in the presence and absence of PSc, 




 High-resolution mass spectrometry of full-length proteins confirmed the incorporation of PSc 
(Figure 3A and B) and in-gel tryptic digestion followed by MS/MS peptide mapping confirmed PSc 
incorporation at the amber codon (Figure S2). The yields of PpiB H147U and ZiPro V36U were, 
respectively, about 4.5 mg and 1.5 mg per liter cell culture, using PSc concentrations of only 1 mM in the 
expression medium.  
 
 
Figure 3. Mass spectra of intact proteins containing PSc and, after decaging, Sec. Observed and expected 
masses are indicated in black and red, respectively. The expected masses were calculated based on the 
masses observed for wild-type PpiB and ZiPro (Figure S3). (A) PpiB H147PSc. (B) ZiPro V36PSc. (C) 
PpiB H147Sec. (D) ZiPro V36Sec.  
 
Photolysis and tagging 
High-resolution mass spectra confirmed the complete conversion of PSc into Sec upon illumination of the 
protein solution at 365 nm at 4 oC (Figure 3C and D). Importantly, dehydroalanine or serine by-products 
were not observed after photolysis, even though these undesired species have often been observed as a 
consequence of selenoprotein oxidation followed by syn-β-elimination of selenenic acid.16,30  
To demonstrate the use of Sec-specific labeling, we alkylated the Sec residue with the 
trimethylsilyl (TMS) tags TMS-1 and TMS-2 (Figure 4A). These tags form thioether bonds with solvent 
exposed cysteine residues and are not suitable for tagging specific cysteine residues in the presence of 
other thiols.31,32 Reaction of these tags with the Sec residue in PpiB H147U and ZiPro V36U, however, 
proceeded quantitatively within 5 minutes at room temperature and pH 5.1. Complete ligation was 
confirmed by high-resolution mass spectrometry (Figure 4B–D). Most importantly, the solvent-exposed 
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free cysteine residues in ZiPro V36PSc at this pH did not react in this short time as thiol groups are less 
reactive.31,32 To probe the reactivity of cysteine residues towards alkylation with TMS-1, we first applied 
the same reaction conditions to wild-type PpiB, wild-type ZiPro, and ZiPro V36U prior to decaging. As 
mass spectra revealed no change in mass, we prolonged the reaction time for the wild-type proteins to 12 
h and increased the pH to 7.5. Under these conditions, the solvent exposed cysteine residues of ZiPro 
were quantitatively alkylated, whereas the buried cysteine residues in PpiB remained intact (Figure S3). 
To probe the reactivity of cysteine residues at the incorporation sites of Sec residues in PpiB H147U and 
ZiPro V36U, we prepared the mutants PpiB H147C and ZiPro V36C/C80S/C143S and reacted the 
proteins with TMS-1 overnight at pH 5.1. Even after 16 h reaction time at room temperature, mass spectra 
and NMR spectra revealed only a limited degree of reaction in PpiB H147C (Figures S4 and S5) and no 
evidence of reaction for the ZiPro mutant (Figure S4). This result highlights the much greater reactivity 
of Sec over Cys even at sites, where alkylation is relatively disfavoured. The pH is very important, 
however, as 5 minutes reaction of decaged ZiPro V36U with TMS-1 at pH 7.5 and room temperature 
resulted in an additional 1H NMR signal of the TMS group at about 15% intensity of the main peak.     
 
Figure 4. Selective Sec labeling with alkylating TMS tags. Observed and expected masses are indicated 
in black and red, respectively. The expected mass increases with TMS-1 and TMS-2 are 143 and 144 Da, 
respectively. Compare with Figure 3C and D for the masses of the untagged selenoproteins. (A) Structures 
of TMS-1 and TMS-2. (B) Mass spectrum of PpiB H147U labeled with TMS-1. (C) Mass spectrum of 
PpiB H147U labeled with TMS-2. (D) Mass spectrum of ZiPro V36U labeled with TMS-2.  
 
1D 1H NMR and ligand binding studies 
The TMS groups of the TMS-1 and TMS-2 tags produce a narrow, intense peak in 1D 1H NMR spectra 
near 0 ppm (Figure 5A and B).31,32 In this spectral region, proteins display few 1H NMR resonances, 
making it easy to identify the TMS signal without assigning the NMR spectrum of the entire protein.32 As 
shown previously, this can be exploited in ligand-binding studies to measure intermolecular NOEs31 and 
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ligand binding affinities.32 The TMS-1 tag is an amide whereas the TMS-2 tag is an ester. Figure 5A shows 
that the TMS-1 tag produces a small additional signal which we attribute to cis-trans isomerization of the 
amide bond, as it is absent from the spectrum with the TMS-2 tag.  
 
 
Figure 5. 1D 1H NMR spectra of PpiB and ZiPro labeled with TMS tags. All spectra were measured at 
25 oC. (A) 1H NMR spectrum of wild-type PpiB and PpiB H147U tagged with TMS-1 or TMS-2. Protein 
concentrations ranged between 10 and 160 μM in 50 mM HEPES, pH 8.0. A red star marks the position 
of a minor species observed with the TMS-1 but not the TMS-2 tag, which is attributed to a cis-amide 
bond of the tag. (B) 1D 1H NMR of wild-type ZiPro and ZiPro V36U tagged with TMS-2. Protein 
concentrations were 50 and 14 μM, respectively, in 20 mM MES, pH 6.8, 150 mM NaCl and 1 mM DTT.  
 
To demonstrate the use of the TMS signals for ligand binding studies, we titrated TMS-1-tagged 
PpiB H147U with the substrate analogue succinyl-Ala-Ala-Pro-Phe-p-nitroanilide (suc-AAPF-pNA).33,34 
The Sec residue is near the substrate binding site (Figure 6A).33 The chemical shift of the TMS signal 
changed gradually with increasing ligand concentration, indicating fast chemical exchange35 with a 
dissociation constant Kd of 12 mM (Figure 6). Based on 2D NMR spectra, a weak binding affinity of suc-





Figure 6. Peptide binding study with PpiB H147U tagged with TMS-1. (A) Substrate binding site of PpiB 
with a Sec-TMS-1 residue modeled at position 147. The protein is displayed in a ribbon representation 
(PDB ID: 1LOP),33 showing the suc-AAPF-pNA peptide in cyan and the TMS group in magenta. (B) 1D 
1H NMR spectra of the TMS signal of PpiB H147U tagged with TMS-1, illustrating the chemical shifts 
observed during titration with suc-AAPF-pNA peptide. The peptide concentrations are indicated. The 
spectra were recorded with a 10 μM protein solution in 50 mM HEPES buffer, pH 8.0, at 25 oC using a 
Bruker 800 MHz NMR spectrometer. (C) Change in chemical shift of the TMS group in response to 
increasing peptide concentration. The binding curve corresponds to the best fit using equation 1. 
 
In ZiPro V36U, the TMS-2 tag is attached close to the catalytic center formed by Ser135, His51, 
and Asp75 (Figure 7A).36 The inhibitor in Figure 7B was previously shown to bind to the triple mutant 
V36C/C80S/C143S of ZiPro tagged with the TMS-2 tag with a Kd value of 64 ± 27 μM.32 The exchange 
between bound and free inhibitor was found to be slow, as determined by the appearance of a new TMS 
peak with increasing inhibitor concentration.32,35 Figure 7C shows the same spectral appearance for ZiPro 
V36U tagged with the TMS-2 tag, confirming that the presence of the wild-type residues Cys80 and 
Cys143 did not affect the tagging. For the concentration of ZiPro V36U protein used in the inhibitor 
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binding experiments (14 μM) and the Kd value (64 μM), about 20% of the protein is expected to be 




Figure 7. Inhibitor binding studies with ZiPro V36U-His6 tagged with TMS-2. (A) Ribbon representation 
of ZiPro (PDB ID: 5LC0),36 showing the NS3 protease domain in green and the NS2B co-factor in yellow. 
The TMS group of the TMS-2 tag attached to the Sec residue at position 36 is shown in magenta and side 
chains of the catalytic triad in blue. (B) Chemical structure of the ZiPro inhibitor. (C) 1D 1H NMR spectra 
of a 14 μM solution of ZiPro V36U tagged with the TMS-2 tag in NMR buffer (20 mM MES, pH 6.8, 
150 mM NaCl, 1 mM DTT). The TMS signal is at about 0.07 ppm. Protein-to-ligand titration ratios are 
indicated. An arrow marks the new peak attributed to the complex, which appears upon titration with 
inhibitor. All spectra were recorded at 25 oC with 14 μM protein solutions. 
 
CONCLUSION 
The site-selective Sec incorporation strategy presented here overcomes a long-standing stumbling block 
for accessing pure selenoproteins in good yield in E. coli and, in principle, with free choice of the insertion 
sites of the Sec residues. Although the bulkiness of a PSc residue could interfere with protein folding, if 
it is placed in a buried site, such interference is less likely to occur for solvent exposed sites which are of 
prime interest for chemical protein modifications. Mm PylRS systems have been shown to be also 
orthogonal in yeast and mammalian expression systems.37−40 The present approach thus establishes a 
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valuable platform for the myriad of FRET, EPR, and NMR tags that have been developed for tagging 
single cysteine residues14−17 and invites many other applications,11 including the use of Sec for expressed 




The Methanosarcina mazei analogue of Methanosarcina barkeri PCC2RS9 (Mm N346Q/C348A/V401M) 
was cloned into NcoI and SacI restriction sites of the modular four-component vector pCDF Duet_4-
components_lac(P1)29 to obtain the plasmid pCDF-Mm PCC2RS/tRNACUA. In addition, the third 
nucleotide of the tRNACUA (G) was replaced by A. (The vector also contained Methanococcus jannaschi 
tRNAUCCU which is not recognized by Mm PCC2RS.)29 All PpiB and ZiPro mutants contained a C-
terminal His6 tag and were cloned into the NdeI and EcoRI sites of the T7 expression vector pETMSCI.41 
The wild-type ZiPro construct was described previously.42 It contained residues 48*–95* of NS2B (where 
the star indicates residues in NS2B) linked to the NS3 protease domain (residues 1–170) by a Gly4SerGly4 
linker. It also contained the mutations R95*A, K15N, and R29G to increase stability towards auto-
cleavage. The ZiPro V36U mutant contained an amber stop codon at position 36. The ZiPro V36C mutant 
had two additional mutations, C80S and C143S, to make C36 the only cysteine residue in the protein. 
 
Expression and purification of PpiB 
PpiB with PSc incorporated at position 147 was produced in E. coli BL21(DE3). The cells were 
transformed with the plasmids pCDF-Mm PCC2RS/tRNACUA and pETMCSI-PpiB H147U-His6 and 
starter cultures grown for 16 h at 37 oC in Luria-Bertani (LB) medium supplemented with 100 µg/mL 
ampicillin and 25 µg/mL spectinomycin. Overnight cultures were inoculated into fresh LB medium (1:100 
dilution), supplemented with ampicillin and spectinomycin, and grown at 37 oC.  After the cultures 
reached an OD600 value of 0.5–0.8, isopropyl-β-D-thiogalactopyranoside (IPTG) and PSc were added to 
final concentrations of 1 mM. The cells were harvested following overnight expression in the dark at room 
temperature. Wild-type PpiB and PpiB H147C were produced in the same way, following transformation 
with the pETMCSI vectors of the respective proteins and growth in the absence of spectinomycin and PSc 
without exclusion of light. The cell pellet was resuspended in buffer A (50 mM phosphate, pH 7.5, 300 
mM NaCl) and lysed by sonication at 4 oC. The lysate was clarified by centrifugation (17300 g, 40 min, 
4 oC) and loaded onto a 5 mL Co-NTA column (GE Healthcare, USA) equilibrated with buffer A. The 
target proteins were eluted using a gradient buffer mixture of buffer A and buffer B (buffer A containing, 
in addition, 300 mM imidazole). For PpiB H147U, buffer B was exchanged for buffer C (50 mM 
phosphate, pH 7.5, 150 mM NaCl, 1 mM DTT, 10% glycerol) for storage at -80 oC or buffer D (100 mM 
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acetate, pH 5.1) for photolysis, using centrifugal filter units with a molecular weight cutoff of 10 kDa 
(Amicon Ultra, Millipore, Billerica, USA). Wild-type PpiB and PpiB H147C were stored in buffer C. 
 
Expression and purification of ZiPro 
ZiPro with PSc incorporated at position 36 was produced in the same way as described above for PpiB, 
except that the protein was expressed using the vector pETMCSI-ZiPro V36U-His6, and the wild-type 
ZiPro and ZiPro V36C/C80S/C143S proteins were expressed similarly using pETMCSI vectors. Mass 
spectra showed that the protein loses its N-terminal methionine during in vivo expression (Figure S3C). 
 
Photolysis 
Decaging of the PSc residue in PpiB H147U and ZiPro V36U was performed in buffer D. Fresh 
dithiothreitol (DTT) was added to a final concentration of 1 mM, the samples were left exposed to nitrogen 
in a low-oxygen glove box for 10 minutes at room temperature, sealed and shaken for another 20 minutes. 
Then the samples were illuminated for 60 min at 4 oC, using a hand-held UV lamp (365 nm, 1200 µW/cm2; 
UVGL-58 from UVP, Cambridge, UK).  
 
Selective Sec labeling 
A five-fold excess of TMS-1 or TMS-2 tag was added to the decaged protein samples and shaken for 5 
min in the dark at room temperature. The reaction was quenched by the addition of 2% β-
mercaptoethanol.15 Excess tag was removed by dialysis into NMR buffer (50 mM HEPES-KOH, pH 8, 
for the PpiB samples and 20 mM MES-KOH, pH 6.8, 150 mM NaCl, 1 mM DTT for the ZiPro samples). 
Control experiments with wild-type ZiPro and ZiPro V36PSc were conducted under the same conditions, 
preparing the protein samples in buffer D, adding fresh DTT to a final concentration of 1 mM, leaving the 
samples in a low-oxygen glove box for 10 minutes at room temperature, sealing and shaking for another 
20 minutes, and finally carrying out the same labeling procedure with TMS-1. 
 
Cysteine labeling 
Fresh DTT was added to a final concentration of 1 mM to solutions of wild-type PpiB and wild-type ZiPro 
in buffer E (50 mM phosphate, pH 7.5, 150 mM NaCl) and the samples were incubated at room 
temperature for 1 hour. Excess DTT was removed by passing the samples through PD10 columns (GE 
Healthcare, USA) before adding a five-fold excess of TMS-1. The reaction mixtures were incubated 
overnight in the dark at room temperature. PpiB H147C and ZiPro V36C/C80S/C143S were labeled with 
TMS-1 in buffer D, pH 5.1, following the same procedure. Reaction rates were quenched for aliquots 





All 1D 1H NMR spectra were recorded of 10-50 μM protein solutions in aqueous buffer containing 10% 
D2O at 25 oC, using a Bruker 800 MHz NMR spectrometer equipped with a TCI cryoprobe. The solvent 
signal was suppressed using the double spin-echo pulse sequence.43 
 
Mass spectrometry 
Mass spectrometry of proteins was carried out using an Orbitrap Elite Hybrid Ion Trap-Orbitrap mass 
spectrometer coupled with an UltiMate 3000 UHPLC (Thermo Scientific, USA). Samples were injected 
into the mass analyser via an Agilent ZORBAX SB-C3 Rapid Resolution HT Threaded Column. 
 
Determination of Kd values 
The dissociation constant Kd was determined by fitting the equation 1 to the data points of Figure 6C. In 
equation 1, ∆δ = 	∆δ%&' ([L] + [P] +	𝐾/) − 2([L] + [P] +	𝐾/)3 − 4[L][P]	2[P] 		(1) 
∆δ is the observed chemical shift difference, ∆δmax the maximal chemical shift difference at saturation, 
and [L] and [P] are the total concentrations of ligand and protein, respectively. The same equation applies 
to signal intensities measured in the limit of slow chemical exchange, with ∆δ replaced by the relative 
signal intensity of the complex and ∆δ max replaced by the total signal intensity of free and bound protein.32 
 
 
Scheme 1. Synthesis of photocaged selenocysteine (PSc). 
 
Synthetic procedures and methods 
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Chemicals and solvents were purchased from standard suppliers and used without further purification. 
Analytical thin-layer chromatography analysis (TLC) was performed on pre-coated silica gel aluminium-
backed plates (Merck Kieselgel 60 F254). Visualisation was by examination under UV light at 254 nm, 
with subsequent staining by KMnO4. Dry-flash column chromatography44 was run using Davisil® P60 
silica gel (40–63µm). Optical rotation was measured in a JASCO P-2000 polarimeter at the sodium D line 
in a cell with 100 mm path length. NMR spectra for compound analysis were recorded on a Bruker NMR 
spectrometer at 400 MHz (1H) and 101 MHz (13C). Chemical shifts (δ) are recorded in parts per million 
(ppm) downfield in relation to tetramethylsilane using the residual solvent as internal standard (CDCl3, 
δH = 7.26 and δC = 77.16; DMSO, δH = 2.50 and δC = 39.52).45 High-resolution mass spectra (HRMS) 
were obtained from an Agilent 6224 TOF LC/MS Mass Spectrometer coupled to an Agilent 1290 Infinity. 
All data were acquired and reference mass corrected via a dual-spray electrospray ionisation (ESI) source. 
Liquid chromatography mass spectrometry (LCMS) was performed with an Agilent 6120 Series Single 
Quad coupled to an Agilent 1260 Series HPLC. The following buffers were used: buffer A: 0.1% formic 
acid in H2O; buffer B: 0.1% formic acid in MeCN. The following gradient was used with a Poroshell 120 
EC-C18 50 x 3.0 mm 2.7 micron column, and a flow rate of 0.5 mL/min and total run time of 5 min: 0–1 
min 95% buffer A and 5% buffer B, from 1–2.5 min up to 0% buffer A and 100% buffer B, held at this 
composition until 3.8 min, 3.8–4 min 95% buffer A and 5% buffer B, held until 5 min at this composition. 
Mass spectra were acquired in positive and negative ion mode with a scan range of 100-1000 m/z. UV 
detection was carried out at 214 and 254 nm.  
 
N-(tert-butoxycarbonyl)-[(R,S)-1-{4',5'-(methylenedioxy)-2'-nitrophenyl}ethyl]-L-selenocysteine. 
The synthesis of photocaged selenocysteine followed Scheme 1. (R,S)-1-Bromo-1-[4',5'-
(methylenedioxy)-2'-nitrophenyl]ethane9 and Boc-L-selenocysteine46 were prepared as previously 
reported. The reaction was run in parallel two times on 1.81 g scale. Sodium borohydride (641 mg, 16.9 
mmol) was added to a cooled (0 °C) solution of Boc-L-selenocysteine (1.81 g, 3.39 mmol) in EtOH (33 
mL), under N2. The mixture was stirred for 15 min at 0 °C and then allowed to warm to room temperature 
(RT) for 15 min. A solution of (R,S)-1-bromo-1-[4',5'-(methylenedioxy)-2'-nitrophenyl]ethane (2.18 g, 
7.94 mmol) in anhydrous THF (13 mL) was then added. The two reactions were then stirred at RT for 18 
h, before quenching with a solution of saturated aqueous NH4Cl/H2O (1:1, 50 mL). The organic solvent 
was removed under reduced pressure and the resultant aqueous mixture from the two reactions were 
combined.  The aqueous was acidified to pH 1 with concentrated HCl (~ 3mL) and then extracted with 
CHCl3 (3 × 100 mL). The combined organics were washed with brine, dried (Na2SO4) and solvent was 
removed under reduced pressure. The crude material was purified by silica dry-flash chromatography, 
eluting with a gradient of 15–35% EtOAc in petroleum benzene, to give the title compound as a yellow 
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foam (3.56 g, 57%). [α]25D = +10.1 (c = 1.10, CHCl3). 1H NMR (400 MHz, CDCl3) δ (Mixture of epimers, 
3:2) 7.31 (s, 1H), 7.15 and 7.13 (2 × s, 1H), 6.10 and 6.09 (2 × d, J = 0.9 Hz, 2H), 5.25 (br s, 1H), 5.01 
(q, J = 6.8 Hz, 1H), 4.61–4.50 (br m, 1H), 3.08–2.97 (br m, 1H), 2.91 (dd, J = 12.5, 5.7 Hz, 1H) 1.70 and 
1.68 (2 × d, J = 5.8 and 6.9 Hz, 3H), 1.44 (s, 9H). 13C NMR (CDCl3) δ (Mixture of epimers) 175.0 (C), 
155.5 (C), 152.0 and 152.0 (C), 146.8 (C), 142.5 and 142.5 (C), 136.2 (C), 108.5 and 108.5 (CH), 105.2 
(CH), 103.1 (CH2), 80.7 (C), 53.5 (CH), 32.5 and 32.4 (CH), 28.4 (CH3), 26.6 and 26.4 (CH2), 23.3 (CH3). 
MS (ES) m/z: 461 [M-H]. LCMS: Rt = 3.36 min; area 100%. HRMS: calcd for C17H22N2O8Se + Na+, 
485.0435; found (ES, [M+Na]+ obsd), 485.0440. Eluting the column with 50% EtOAc in petroleum 
benzene, followed by 15% MeOH in DCM gave Boc-L-selenocysteine as a pale brown foam (1.44 g, 
40%). Spectroscopic data were in agreement with those reported.16 
[(R,S)-1-{4',5'-(methylenedioxy)-2'-nitrophenyl}ethyl]-L-selenocysteine trifluoroacetate. TFA (27 
mL) was added to N-(tert-butoxycarbonyl)-[(R,S)-1-{4',5'-(methylenedioxy)-2'-nitrophenyl}ethyl]-L-
selenocysteine (3.72 g, 8.06 mmol) and the resultant solution was stirred at RT for 10 min. Volatile 
components were removed under reduced pressure at 20 °C. The obtained residue was dissolved in MeCN 
(8 mL) and precipitated into Et2O (200 mL) by slow addition while stirring vigorously, in a round bottom 
flask. The solvent was decanted and the solid was washed with Et2O (50 mL). After decanting, final traces 
of solvent were removed under reduced pressure to give the title compound as a yellow hydroscopic solid 
(2.87 g, 75%). [α]26D = -0.3 (c = 1.00, DMSO). 1H NMR (400 MHz, DMSO-d6) δ (Mixture of epimers, 
1:1) 7.49 and 7.48 (2 × s, 1H), 7.29 and 7.28 (2 × s, 1H), 6.21 and 6.20 (2 × s, 2H), 4.79 and 4.77 (2 × q, 
J = 7.0 and 7.0 Hz, 1H), 3.59–3.50 (br m, 1H), 2.95 and 2.87 (2 × dd, J = 12.5, 5.3 and 12.5, 5.5 Hz, 1H), 
2.81–2.71 (br m, 1H), 1.67 and 1.65 (2 × d, J = 7.0 and 7.0 Hz, 3H). 13C NMR (DMSO-d6) δ (Mixture of 
epimers) 169.2 and 169.2 (C), 151.6 and 151.6 (C), 146.4 and 146.4 (C), 142.0 and 141.8 (C), 135.7 and 
135.5 (C), 108.1 and 108.0 (CH), 104.7 and 104.6 (CH), 103.3 (CH2), 53.7 and 53.6 (CH), 32.2 and 31.8 
(CH), 24.7 and 24.5 (CH2), 22.5 and 22.5 (CH3). MS (ES) m/z: 361 [M-H]. LCMS: Rt = 2.82 min; area 
98%. HRMS: calcd for C12H14N2O6Se + H+, 363.0090; found (ES, [M+H]+ obsd), 363.0093. 
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